ciprofloxacine teva

Ciprofloxacine Teva is a generic formulation of the broad-spectrum fluoroquinolone antibiotic ciprofloxacin, developed and manufactured by Teva Pharmaceuticals. It functions by targeting and inhibiting bacterial DNA gyrase (topoisomerase II) and topoisomerase IV, enzymes critical for the separation of bacterial DNA during replication, thereby inducing double-stranded DNA breaks and cell death. While ciprofloxacin is widely approved for various bacterial infections including urinary tract, respiratory, and gastrointestinal infections, this specific generic version is being investigated by Amsterdam UMC and Proctos kliniek in clinical trials (such as the ABScess trial) to determine its efficacy in reducing recurrence and fistula formation following the surgical drainage of perianal abscesses.

Brand names

Ciprofloxacine Teva

Other names

ciprofloxacin teva